Understanding how incomplete DNA replication leads to genetic changes

Cell cycle timing and molecular mechanisms of structural variant formation following incomplete replication

['FUNDING_R01'] · UNIVERSITY OF MICHIGAN AT ANN ARBOR · NIH-11052493

This study is looking at how mistakes in DNA copying can lead to cancer and genetic diseases, and it's for anyone interested in understanding how our cells fix these mistakes and what happens when they don't.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF MICHIGAN AT ANN ARBOR (nih funded)
Locations1 site (ANN ARBOR, UNITED STATES)
Trial IDNIH-11052493 on ClinicalTrials.gov

What this research studies

This research investigates the mechanisms behind genetic mutations that occur when DNA replication is incomplete, which can lead to cancer and genetic diseases. By studying how structural variants, particularly copy number variants, form during this process, the research aims to fill gaps in our understanding of DNA repair mechanisms. The approach involves using human cell models to observe the effects of incomplete replication and the resulting genetic changes. This could provide insights into the timing and molecular processes involved in these mutations.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with a family history of genetic diseases or cancers related to DNA replication errors.

Not a fit: Patients with conditions unrelated to DNA replication or structural variants may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and potential treatments for cancers and genetic diseases caused by DNA replication errors.

How similar studies have performed: Previous research has shown promising results in understanding DNA repair mechanisms, suggesting that this approach could yield valuable insights.

Where this research is happening

ANN ARBOR, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Breast Cancer 2 Gene, Breast Cancer Type 2 Susceptibility Gene, Cancers

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.